passages.id: split_6_test_1551_passage
passages.type: progene_text
passages.text: Patients received escalating doses of peptide - pulsed DCs at 10e7 , 3 x 10e7 , and 10e8 cells / dose twice at 2 weeks apart , with toxicity and clinical and immune responses as the principal endpoints .